[HTML][HTML] Host-directed therapies for bacterial and viral infections

SHE Kaufmann, A Dorhoi, RS Hotchkiss… - Nature reviews Drug …, 2018 - nature.com
Despite the recent increase in the development of antivirals and antibiotics, antimicrobial
resistance and the lack of broad-spectrum virus-targeting drugs are still important issues and …

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

S Tiberi, N du Plessis, G Walzl, MJ Vjecha… - The Lancet Infectious …, 2018 - thelancet.com
Tuberculosis remains the world's leading cause of death from an infectious disease,
responsible for an estimated 1 674 000 deaths annually. WHO estimated 600 000 cases of …

[HTML][HTML] New developments in anti-malarial target candidate and product profiles

JN Burrows, S Duparc, WE Gutteridge… - Malaria journal, 2017 - Springer
A decade of discovery and development of new anti-malarial medicines has led to a
renewed focus on malaria elimination and eradication. Changes in the way new anti …

[HTML][HTML] Neutrophil extracellular traps in pulmonary diseases: too much of a good thing?

BN Porto, RT Stein - Frontiers in immunology, 2016 - frontiersin.org
Neutrophil extracellular traps (NETs) arise from the release of granular and nuclear contents
of neutrophils in the extracellular space in response to different classes of microorganisms …

A systematic review of biomarkers to detect active tuberculosis

E MacLean, T Broger, S Yerlikaya… - Nature …, 2019 - nature.com
Millions of cases of tuberculosis (TB) go undiagnosed each year. Better diagnostic tools are
urgently needed. Biomarker-based or multiple marker biosignature-based tests, ideally …

Tuberculosis treatment monitoring and outcome measures: new interest and new strategies

J Heyckendorf, SB Georghiou, N Frahm… - Clinical microbiology …, 2022 - Am Soc Microbiol
Despite the advent of new diagnostics, drugs and regimens, tuberculosis (TB) remains a
global public health threat. A significant challenge for TB control efforts has been the …

The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules

P Brandao, C Marques, AJ Burke, M Pineiro - European journal of …, 2021 - Elsevier
Oxindole derivatives are known for their great interest in the field of Medicinal Chemistry, as
they display vast biological activities. Recent efforts concerning the preparation of oxindole …

[HTML][HTML] New drugs and perspectives for new anti-tuberculosis regimens

S Tiberi, M Muñoz-Torrico, R Duarte, M Dalcolmo… - Pulmonology, 2018 - Elsevier
Tuberculosis (TB) is the ninth cause of global death, more than any other infectious disease.
With growing drug resistance the epidemic remains and will require significant attention and …

[HTML][HTML] Chronic physical conditions, multimorbidity and physical activity across 46 low-and middle-income countries

D Vancampfort, A Koyanagi, PB Ward… - International Journal of …, 2017 - Springer
Background There are no nationally representative population-based studies investigating
the relationship between physical activity, chronic conditions and multimorbidity (ie, two or …

[HTML][HTML] Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α

LB Tezera, MK Bielecka, P Ogongo, NF Walker, M Ellis… - Elife, 2020 - elifesciences.org
Previously, we developed a 3-dimensional cell culture model of human tuberculosis (TB)
and demonstrated its potential to interrogate the host-pathogen interaction (Tezera et al …